When evaluating affordable tirzepatide options , the compound blend should be assessed on a cost-per-benefit basis
Funding This work was supported by a R01MH128311 and a R56MH125895 to CN
The most frequent adverse effects are gastrointestinal and dose-related: Nausea, vomiting, diarrhoea, constipation, and abdominal discomfort - Typically worst during dose escalation and often resolve or attenuate with continued treatment and slower titration
Zha M, Li F, Xu W, Chen B, Sun Z (2014) Isolation and characterization of islet stellate cells in rat
Limited human studies : While there is a growing body of anecdotal evidence supporting its benefits, clinical trials in humans are limited